Business Segments · Total segment depreciation and amortization
Oncology & Multispecialty — Total segment depreciation and amortization
McKesson Oncology & Multispecialty — Total segment depreciation and amortization remained flat by 0.0% to $60M in Q4 2026 compared to the prior quarter. Year-over-year, this metric declined by 4.8%, from $63M to $60M.
Analysis
StatementSegment
CategoryEfficiency
SignalContext dependent
VolatilityStable
First reportedQ3 2024
Last reportedQ4 2026May 8, 2026
Rolls up toD&A
How to read this metric
Rising levels often indicate significant recent capital investment, whereas declining levels may suggest aging assets or reduced investment intensity.
Detailed definition
The total non-cash expense allocated to the Oncology and Multispecialty segment related to the systematic write-down of...
Peer comparison
Standard across all capital-intensive industries; comparable to 'Segment D&A' reported by peers like Cencora or Cardinal Health.
Metric ID:
mck_segment_oncology_multispecialty_total_segment_depreciation_and_amortizationHistorical Data
8 periods
| Q3 '24 | Q4 '24 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | Q4 '26 | |
|---|---|---|---|---|---|---|---|---|
| Value | $37M | $37M | $71M | $63M | $60M | $60M | $60M | $60M |
| QoQ Change | — | +0.0% | +91.9% | -11.3% | -4.8% | +0.0% | +0.0% | +0.0% |
| YoY Change | — | — | +91.9% | +70.3% | — | — | -15.5% | -4.8% |
Range$37M – $71M
CAGR+31.8%
Avg YoY Growth+35.5%
Median YoY Growth+32.8%
Current Streak3 quarters growth
Similar Metrics at Other Companies
Frequently Asked Questions
- What is McKesson's oncology & multispecialty — total segment depreciation and amortization?
- McKesson (MCK) reported oncology & multispecialty — total segment depreciation and amortization of $60M in Q4 2026.
- How has McKesson's oncology & multispecialty — total segment depreciation and amortization changed year-over-year?
- McKesson's oncology & multispecialty — total segment depreciation and amortization decreased by 4.8% year-over-year, from $63M to $60M.
- What does oncology & multispecialty — total segment depreciation and amortization mean?
- The total non-cash cost of wearing out or using up assets within the Oncology and Multispecialty segment.